Cogent Biosciences Inc (COGT)
8.91
-0.74
(-7.67%)
USD |
NASDAQ |
Nov 15, 16:00
9.27
+0.36
(+4.04%)
After-Hours: 18:31
Cogent Biosciences Shareholders Equity (Quarterly): 373.22M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 373.22M |
| March 31, 2024 | 422.33M |
| December 31, 2023 | 257.80M |
| September 30, 2023 | 302.90M |
| June 30, 2023 | 348.43M |
| March 31, 2023 | 223.56M |
| December 31, 2022 | 255.74M |
| September 30, 2022 | 289.94M |
| June 30, 2022 | 319.38M |
| March 31, 2022 | 187.86M |
| December 31, 2021 | 214.18M |
| September 30, 2021 | 197.24M |
| June 30, 2021 | 212.80M |
| Date | Value |
|---|---|
| March 31, 2021 | 226.76M |
| December 31, 2020 | 234.67M |
| September 30, 2020 | 116.06M |
| June 30, 2020 | 19.24M |
| March 31, 2020 | 25.70M |
| December 31, 2019 | 31.76M |
| September 30, 2019 | 28.62M |
| June 30, 2019 | 39.76M |
| December 31, 2018 | 60.23M |
| September 30, 2018 | 67.53M |
| June 30, 2018 | 76.68M |
| March 31, 2018 | 15.90M |
| December 31, 2017 | 28.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
19.24M
Minimum
Jun 2020
422.33M
Maximum
Mar 2024
224.19M
Average
226.76M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 429.94M |
| Total Liabilities (Quarterly) | 56.71M |